Companies
- Companies
- Company details
Pharmexa
Therapeutic vaccine technology to downregulate self-proteinsThe company in detail
Summary
Founded in 1990, Pharmexa is a biotechnology company focusing on the development of novel immunotherapy drugs to treat oncological and inflammatory diseases. Pharmexa's aim is to become the leading active immunotherapy company in the world, because the company believes this position will be attractive to hold in the second half of this decade.
Partnerships
To view this information, you must subscribe to Pharmalicensing Intelligence.
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Senior management
To view this information, you must subscribe to Pharmalicensing Intelligence.
Board of directors
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 56 pages - $500
May 2011 - 26 pages - $500
Dec 2010 - 31 pages - $500
Mar 2011 - 57 pages - $250
Dec 2010 - 26 pages - $500
Dec 2006 - 103 pages - $2,875
Jul 2011 - 61 pages - $500
Mar 2011 - 43 pages - $500
Nov 2006 - 270 pages - $3,500
Nov 2010 - 60 pages - $500
Contact details
To view this information, you must subscribe to Pharmalicensing Intelligence.
Head office
Related companies
Related categories
- Industry sector
- Biotechnology / Human therapeutics
- Therapeutic target
- Allergy
- Cardiovascular
- Central Nervous System
- Dermatological
- Gastrointestinal
- Immune related disorders
- Musculoskeletal
- Oncology
- Respiratory
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us